BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Will Geist, President, Protein Sciences Segment, will present at the KeyBanc Life...
Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Will Geist, President, Protein Sciences Segment, will present at the KeyBanc Life...
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Barclays...
MASS earnings call for the period ending December 31, 2021.
UBS Group AG increased its position in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 22.9% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 27,241 shares of the biotechnology company’s stock after purchasing an additional 5,083 shares during the period. UBS Group AG’s holdings in Bio-Techne were […]
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 11th...